EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Relative and bedside nurse assessment of comfort and communication during propofol, dexmedetomidine, or clonidine-based sedation: pre-planned analysis within the A2B RCT

Timothy S Walsh iD, Richard A Parker iD, Leanne M Aitken iD, Cathrine A McKenzie iD, Robert Glen iD, Christopher J Weir iD

Health Technology Assessment · 2026

DOI: 10.3310/gjtw2718 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Health Technology Assessment, 2026. Verfasst von Timothy S Walsh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Usher Institute, The University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Clonidine, Dexmedetomidine, Hypnotics and Sedatives, Patient Comfort. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimising comfort and ability to communicate for mechanically ventilated intensive care unit patients is a priority for clinicians, intensive care unit patients and their relatives. Current usual care is propofol-based sedation plus an opioid analgesic. The alpha2-agonists dexmedetomidine and clonidine are potential alternative sedatives. Objective(s) To explore whether nurses and relatives perceive patients sedated with dexmedetomidine and/or clonidine appear more awake, comfortable and co-operative than patients receiving only propofol-based sedation. Design and methods Substudy within an open-label, three-arm trial. Setting and participants Forty-one intensive care units in the United Kingdom. One thousand four hundred and thirty-seven adults receiving propofol ± opioid for sedation-analgesia within 48 hours of starting mechanical ventilation, expected to require ≥ 48 total hours of mechanical ventilation.

Interventions

Light sedation was targeted in all patients unless clinicians requested deeper sedation. In intervention groups, algorithms promoted alpha2-agonist up-titration and propofol down-titration, followed by sedation primarily with allocated alpha2-agonist. Usual care was propofol-based sedation. Intervention continued until patients were successfully extubated (primary outcome), or other pre-defined end points. Outcomes For each 12-hour care period, nurses responded to two ‘yes/no’ questions: is the patient able to communicate pain? Is the patient able to co-operate with care? When the patients’ personal legal representative visited, they were asked for ‘yes/no’ responses to three questions: does the patient appear awake? Does the patient appear comfortable? Does the visitor feel they can communicate with the patient? Intervention versus propofol group responses were compared fitting a generalised linear mixed model, with results expressed as odds ratios (95% confidence intervals); odds ratios > 1 indicated greater probability of a ‘yes’ response.

Results

Nurse responses were available for > 90% of trial patients [mean (standard deviation) 12 (12) care periods per patient]. Comparing dexmedetomidine versus propofol groups, the odds ratio for a ‘yes’ response to ‘ communicate pain ’ was 1.38 (95% confidence interval 1.08 to 1.75), and for clonidine versus propofol, it was 1.13 (0.89 to 1.43). For ‘ co-operate with care ’ comparing dexmedetomidine versus propofol groups, the odds ratio was 1.14 (95% confidence interval 0.98 to 1.32), and for clonidine versus propofol, it was 0.96 (95% confidence interval 0.83 to 1.12). Relative responses were available for 32–34% of trial patients across groups [mean (standard deviation) 3 (3) days per patient]. For the ‘ appear awake ’ question, the dexmedetomidine versus propofol group odds ratio was 1.48 (95% confidence interval 1.04 to 2.10), and for clonidine versus propofol, it was 1.35 (95% confidence interval 0.95 to 1.91). For ‘ appear comfortable ’, the dexmedetomidine versus propofol group odds ratio was 0.64 (95% confidence interval 0.38 to 1.09), and for clonidine versus propofol, it was 0.78 (95% confidence interval 0.45 to 1.34). For the ‘ feel they can communicate ’ comparison, the dexmedetomidine versus propofol group odds ratio was 1.00 (95% confidence interval 0.68 to 1.47), and for clonidine versus propofol, it was 1.05 (95% confidence interval 0.71 to 1.54).

Limitations

Interventions were unblinded, with risk of bias; missing data may not have been at random.

Conclusions

Nurses perceived patients receiving dexmedetomidine-based sedation could better communicate pain than with propofol-based sedation, and relatives perceived patients appeared more awake. No differences for the other questions were found, or for the clonidine versus propofol comparisons, although some uncertainty remains due to the wide confidence intervals. Future work Additional mixed-methods research of sedation quality with different agents from staff and relative perspectives. Funding This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16/93/01.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClonidineDexmedetomidineHypnotics and SedativesPatient ComfortPropofolAdultAgedFemaleHumansMaleMiddle AgedAdrenergic alpha-2 Receptor AgonistsCommunicationIntensive Care UnitsRespiration, ArtificialUnited Kingdom

Stichwörter der Autor:innen

ADRENERGIC ALPHA-2 RECEPTOR AGONISTSARTIFICIALCLONIDINECRITICAL CAREDEXMEDETOMIDINEHYPNOTICS AND SEDATIVESINTENSIVE CARE UNITSRESPIRATION

Substanzen

Adrenergic alpha-2 Receptor AgonistsClonidineDexmedetomidineHypnotics and SedativesPropofol

Autor:innen und Institutionen

  • Usher Institute, The University of Edinburgh, Edinburgh, UK.
  • Edinburgh Clinical Trials Unit, Usher Institute, The University of Edinburgh, Edinburgh, UK.
  • City St George's, University of London, London, UK.
  • NIHR Southampton Biomedical Research Centre, Perioperative and Critical Care Theme, University of Southampton, Southampton, UK.
  • Lay Member, Edinburgh, UK.

ORCID-Profile: Timothy S Walsh, Richard A Parker, Leanne M Aitken, Cathrine A McKenzie, Robert Glen, Christopher J Weir

Förderung

  • Health Technology Assessment programme

Zitieren

APA

Walsh, T. S., Parker, R. A., Aitken, L. M., McKenzie, C. A., Glen, R., & Weir, C. J. (2026). Relative and bedside nurse assessment of comfort and communication during propofol, dexmedetomidine, or clonidine-based sedation: pre-planned analysis within the A2B RCT. Health Technology Assessment. https://doi.org/10.3310/gjtw2718

Vancouver

Walsh TS, Parker RA, Aitken LM, McKenzie CA, Glen R, Weir CJ. Relative and bedside nurse assessment of comfort and communication during propofol, dexmedetomidine, or clonidine-based sedation: pre-planned analysis within the A2B RCT. Health Technology Assessment. 2026. doi:10.3310/gjtw2718

BibTeX
@article{Walsh2026,
  author = {Walsh, Timothy S and Parker, Richard A and Aitken, Leanne M and McKenzie, Cathrine A and Glen, Robert and Weir, Christopher J},
  title = {Relative and bedside nurse assessment of comfort and communication during propofol, dexmedetomidine, or clonidine-based sedation: pre-planned analysis within the A2B RCT},
  journal = {Health Technology Assessment},
  year = {2026},
  doi = {10.3310/gjtw2718}
}
Kostenlos starten →